首页> 外文期刊>Acta Neurochirurgica >Management and outcome of high-grade multicentric gliomas: A contemporary single-institution series and review of the literature
【24h】

Management and outcome of high-grade multicentric gliomas: A contemporary single-institution series and review of the literature

机译:高档多中心神经胶质瘤的治疗和转归:当代单机构系列研究和文献综述

获取原文
获取原文并翻译 | 示例
           

摘要

Background Multicentric malignant gliomas are wellseparated tumours in different lobes or hemispheres, without anatomical continuity between lesions. The purpose of this study was to explore the clinical features, the pathology and the outcome according to the management strategies in a consecutive series of patients treated at a single institution. In addition, an analysis of the existing literature is presented. Methods For the institutional analysis, a retrospective review of all patients who underwent treatment for multicentric gliomas in the last 7 years was performed. For the analysis of the literature, a MEDLINE search with no date limitations was accomplished for surgical treatment of multicentric malignant gliomas. Results Two hundred and thirty-nine patients with glioma were treated in our department. Eighteen patients (7.5%) with a mean age of 64 years (age range, 37-78 years) presented multicentric malignant gliomas. Thirteen patients (72 %) underwent surgical resection of at least one lesion that was followed by adjuvant treatment in all but one case. Five patients (28 %) underwent stereotactic biopsy and thereafter received chemotherapy. A survival advantage was associated with resection of at least one lesion followed by adjuvant treatment (median overall survival 12 months) compared with 4 months for stereotactic biopsy followed by chemotherapy. Similar results were obtained from the review of the literature. Conclusions Resection of at least one lesion seems to play a significant role in the management of selected patients with multicentric malignant gliomas. Multi-institutional studies on larger series are warranted to define how aggressively the patients with malignant multicentric gliomas should be treated.
机译:背景多中心恶性神经胶质瘤是在不同的叶或半球中分离良好的肿瘤,病变之间没有解剖上的连续性。这项研究的目的是根据在单个机构接受治疗的连续系列患者的治疗策略,探讨其临床特征,病理学和结局。此外,对现有文献进行了分析。方法为进行机构分析,对过去7年中所有接受过多中心胶质瘤治疗的患者进行了回顾性回顾。为了分析文献,完成了无日期限制的MEDLINE搜索,用于多中心恶性神经胶质瘤的手术治疗。结果我科诊治胶质瘤239例。平均年龄为64岁(年龄范围为37-78岁)的18例患者(7.5%)表现为多中心恶性神经胶质瘤。 13例患者(72%)接受了至少一个病变的手术切除,除1例外,全部接受了辅助治疗。五名患者(28%)接受了立体定向活检,随后接受了化疗。生存优势与至少一个病变的切除,辅助治疗(中位总生存期为12个月)相关,而立体定向活检和化疗则为4个月。从文献回顾中获得了相似的结果。结论切除至少一个病变似乎在选择多中心恶性神经胶质瘤患者的治疗中起着重要作用。有必要对较大系列进行多机构研究,以定义应如何积极治疗恶性多中心神经胶质瘤患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号